Rep. Steve Owens

Maddy summaryThis bill amends Massachusetts laws to strengthen protections for workers injured on the job by requiring the state department to investigate all injury claims and hold conferences to gather evidence, regardless of whether a dispute is currently active. It also expands the legal remedies available to injured workers by allowing for punitive damages and injunctive relief in cases where employers violate specific safety regulations. Additionally, the legislation updates fee schedules and clarifies the types of damages that can be recovered when workers file complaints against employers for failing to meet safety standards.

Senate, October 30, 2023 -- The committee on Health Care Financing, to whom was referred the petitions (accompanied by bill, Senate, No. 732) of John J. Cronin for legislation to promote comprehensive transparency in the pharmaceutical industry; (accompanied by bill, Senate, No. 749) of Cindy F. Friedman, Rebecca L. Rausch, Susannah M. Whipps, Joanne M. Comerford and other members of the General Court for legislation relative to pharmaceutical access, costs and transparency; (accompanied by bill, Senate, No. 767) of Jason M. Lewis for legislation to define modest meals and refreshments in prescriber education settings; (accompanied by bill, Senate, No. 778) of Paul W. Mark for legislation to bring down the cost of prescription drugs; (accompanied by bill, Senate, No. 783) of Mark C. Montigny and Michael J. Barrett for legislation to promote transparency and prevent price gouging of pharmaceutical drug prices; (accompanied by bill, Senate, No. 784) of Mark C. Montigny for legislation relative to coverage for chronic illness; (accompanied by bill, Senate, No. 797) of Jacob R. Oliveira for legislation to bring down the cost of prescription drugs; (accompanied by bill, House, No. 619) of Nicholas A. Boldyga relative to establishing a prescription drug rebate program for seniors; (accompanied by bill, House, No. 1176) of Edward F. Coppinger and others relative to promoting comprehensive transparency in the pharmaceutical industry; (accompanied by bill, House, No. 1201) of Kate Hogan relative to the pricing of prescription drugs; (accompanied by bill, House, No. 1205) of Bradley H. Jones, Jr., and others that the Health Policy Commission and health insurers create listings of certain high cost prescription drugs and that the Attorney General require drug manufacturers to provide information to justify increases in costs; (accompanied by bill, House, No. 1206) of Bradley H. Jones, Jr., and others for an investigation by a special commission (including members of the General Court) relative to contracts between the MassHealth program and pharmaceutical benefit managers; (accompanied by bill, House, No. 1215) of John J. Lawn, Jr., and others relative to pharmacy benefit managers; (accompanied by bill, House, No. 1246) of William M. Straus relative to drug prices paid by carriers; and (accompanied by bill, House, No. 1247) of Alyson M. Sullivan-Almeida, Michael J. Soter and David F. DeCoste relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth, reports the accompanying bill (Senate, No. 2492).

Maddy summaryThis bill aims to improve care for medically fragile children by requiring the state to fill a growing percentage of authorized skilled nursing hours through MassHealth, targeting 75% by 2023, 80% by 2024, and 85% by 2025. It mandates that any budget increases used for this purpose can be directed toward raising nurse wages and requires the state to submit annual reports on the number of filled hours, appeals, and reductions in authorized care. Additionally, the bill directs the Medicaid office to review and report on wage rates paid to home health agencies providing these services, ensuring transparency for lawmakers.

Maddy summaryThis bill amends Massachusetts laws to formally include pharmacy benefit managers in state regulations regarding pharmaceutical pricing and market oversight. The key changes require these companies to pay the same fees as drug manufacturers when state spending on medications rises, while exempting those who also provide their own pharmacy services from extra charges. Additionally, the legislation expands the scope of investigations and reporting requirements to explicitly include pharmacy benefit managers alongside other industry players. By updating existing legal definitions and fee structures, the bill aims to ensure these entities are held accountable for their role in the state's healthcare costs.

Maddy summaryThis bill creates a new health coverage program for children and young adults under 21 in Massachusetts who currently lack access to MassHealth solely because of their immigration status. It allows these individuals to receive comprehensive health benefits similar to those available to other residents who meet standard income and age requirements, regardless of whether they qualify for federal funding. The law mandates that the state maximize available federal money for these benefits but ensures that eligibility is not dependent on receiving that federal support.

Maddy summaryThis bill establishes a new chapter in Massachusetts law to ensure state agencies provide timely and culturally competent language services to individuals with limited English proficiency. It requires agencies to create written language access plans that outline specific tasks, deadlines, and responsible personnel to guarantee equal access to public services. The legislation defines key terms such as "equal access" and "culturally competent" to guide how agencies must communicate with non-English speakers. By mandating these administrative blueprints, the law aims to remove language barriers for residents seeking government assistance, programs, or activities.